World Health Organization. Global Hepatitis Report 2017. Geneva, Switzerland: World Health Organization; 2017.
2.
BasnayakeSKEasterbrookPJ. Wide variation in estimates of global prevalence and burden of chronic hepatitis B and C infection cited in published literature. J Viral Hepat. 2016;23:545-559.
3.
QiuLBinnsCWZhaoYZhangKXieX. Hepatitis B and breastfeeding in Hangzhou, Zhejiang Province, People’s Republic of China. Breastfeed Med. 2010;5:109-112.
4.
CapilenoYAVan den BerghRDonchunkD. Management of chronic hepatitis C at a primary health clinic in the high-burden context of Karachi, Pakistan. PLoS One. 2017;12:e0175562.
5.
Andrieux-MeyerICohnJde AraujoESAHamidSS. Disparity in market prices for hepatitis C virus direct-acting drugs. Lancet Glob Health. 2015;3:E676-E677.
HayesCNChayamaK. Why highly effective drugs are not enough: the need for an affordable solution to eliminating HCV. Expert Rev Clin Pharmacol. 2017;10:583-594.
11.
NavarroVJKhanIBjornssonESeeffLBSerranoJHoofnagleJH. Liver injury from herbal and dietary supplements. Hepatology. 2017;65:363-373.
12.
ChenJGKenslerTW. Changing rates for liver and lung cancers in Qidong, China. Chem Res Toxicol. 2014;27:3-6.
13.
World Hepatitis Alliance. Why Do We Continue to Put Our Children at Unnecessary Risk of Liver Cancer?Geneva, Switzerland: World Hepatitis Alliance; 2017.